David C. Hastings
2018 - Arbutus Biopharma Corp
In 2018, David C. Hastings earned a total compensation of $1.5M as Chief Financial Officer at Arbutus Biopharma Corp.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $147,200 |
| Option Awards | $1,002,000 |
| Salary | $224,000 |
| Other | $4,667 |
| Total | $1,452,867 |
Hastings received $1M in option awards, accounting for 69% of the total pay in 2018.
Hastings also received $75K in bonus, $147.2K in non-equity incentive plan, $224K in salary and $4.7K in other compensation.
Rankings
In 2018, David C. Hastings' compensation ranked 7,316th out of 14,244 executives tracked by ExecPay. In other words, Hastings earned more than 48.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,316 out of 14,244 | 49th |
Division Manufacturing | 2,832 out of 5,765 | 51st |
Major group Chemicals And Allied Products | 1,064 out of 2,128 | 50th |
Industry group Drugs | 899 out of 1,817 | 51st |
Industry Pharmaceutical Preparations | 703 out of 1,391 | 50th |
Source: SEC filing on April 23, 2019.
Hastings' colleagues
We found two more compensation records of executives who worked with David C. Hastings at Arbutus Biopharma Corp in 2018.